(PharmaNewsWire.Com, August 01, 2017 ) In this report, we analyze the Laboratory Burner industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers...
(PharmaNewsWire.Com, August 01, 2017 ) In this report, we analyze the Laboratory Heating Plate industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers...
(PharmaNewsWire.Com, August 01, 2017 ) Prostate Cancer - Heat Map and AnalysisProstate cancer (PC) is a type of cancer that affects the prostate gland of the male reproductive system, and is the most common non-cutaneous malignant cancer in men. Internationally, it is the sixth-largest cancer-related...
(PharmaNewsWire.Com, August 01, 2017 ) Pressure Regulator is a valve that automatically cuts off the flow of a liquid or gas at a certain pressure. Regulators are used to allow high-pressure fluid supply lines or tanks to be reduced to safe and/or usable pressures for various applications.Scope...
(PharmaNewsWire.Com, August 01, 2017 ) Rheumatoid Arthritis - Heat Map and AnalysisRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. Disease progression results in stiffness and pain, especially in the hands and feet,...
(PharmaNewsWire.Com, August 01, 2017 ) Hepatitis C is a blood-borne viral infection characterized by chronic inflammation of the liver. Although patients may be asymptomatic for a number of years or decades, chronic HCV infection can lead to liver fibrosis (formation of scar tissue) and ultimately...
(PharmaNewsWire.Com, August 01, 2017 ) "Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors. The Report covers the product profiles...
(PharmaNewsWire.Com, August 01, 2017 ) Report, "Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
(PharmaNewsWire.Com, August 01, 2017 ) Glaucoma -Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The...
(PharmaNewsWire.Com, August 01, 2017 ) This report studies Shock Absorber in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.This report...
(PharmaNewsWire.Com, August 01, 2017 ) Publisher's, "G-CSF Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the G-CSF Inhibitors. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, August 01, 2017 ) Gastrointestinal Stromal Tumors (GIST) -Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany,...
(PharmaNewsWire.Com, August 01, 2017 ) " Gastrointestinal Stromal Tumor (GIST)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Gastrointestinal Stromal Tumor (GIST). The Report covers the product profiles in various stages...
(PharmaNewsWire.Com, August 01, 2017 ) Publisher's, "GABAB Modulators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the GABAB Modulators. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, August 01, 2017 ) Publisher's, "GABAB Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the GABAB Agonists. The Publisher's Report covers the product profiles in various stages of development including...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
